WGS (GeneDx Holdings Corp.) Stock Financials & Earnings

WGSGeneDx Holdings Corp.

Mkt Cap$3B

Revenue (TTM)$428M

Net Income (TTM)-$21M

EPS (TTM)-$0.73

Free Cash Flow (TTM)$14M

Gross Margin68.5%

Op. Margin-2.9%

Net Margin-4.9%

FCF Margin3.3%

P/S Ratio (TTM)6.3x

P/E Ratio (TTM)—

YoY Rev Growth+40.0%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$43M	$15M	-$60M
Q2 23	$49M	$19M	-$52M
Q3 23	$53M	$25M	-$43M
Q4 23	$57M	$31M	-$26M
Q1 24	$62M	$37M	-$14M
Q2 24	$71M	$43M	-$11M
Q3 24	$77M	$48M	-$8M
Q4 24	$96M	$66M	$9M
Q1 25	$87M	$58M	-$5M
Q2 25	$103M	$71M	$9M
Q3 25	$117M	$85M	-$3M
Q4 25	$121M	$79M	-$14M

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 23	$15M	$44M	$13M
Q2 23	$17M	$37M	$15M
Q3 23	$14M	$26M	$17M
Q4 23	$12M	$27M	$16M
Q1 24	$12M	$23M	$16M
Q2 24	$11M	$26M	$17M
Q3 24	$12M	$26M	$17M
Q4 24	$12M	$27M	$18M
Q1 25	$13M	$32M	$18M
Q2 25	$15M	$27M	$19M
Q3 25	$20M	$44M	$24M
Q4 25	$24M	$47M	$27M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$214M	$0	$214M
Q2 23	$157M	$0	$157M
Q3 23	$87M	$27M	$114M
Q4 23	$100M	$30M	$130M
Q1 24	$84M	$29M	$113M
Q2 24	$56M	$51M	$107M
Q3 24	$58M	$59M	$116M
Q4 24	$85M	$56M	$141M
Q1 25	$100M	$59M	$159M
Q2 25	$74M	$60M	$135M
Q3 25	$96M	$59M	$155M
Q4 25	$105M	$66M	$171M

Shares Outstanding

Revenue Per Employee

Revenue / Employee